The US patent system drives growth and innovation worldwide. The majority of the more than 300,000 U.S. patents issued each year (and rising) are reviewed by only 1 patent examiner. Additionally, 58% are issued to foreign inventors or entities.
Unfortunately, these patents are regularly asserted against U.S. manufacturers, diverting resources from U.S. companies' coffers. Built on a foundation of purchased low-quality patents, these litigations have cost U.S. inventors and companies more in patent litigation costs and damages awards than any other jurisdiction in the world.
Instead of seeking to improve patent quality, many licensing-focused non-practicing companies have sought to ease enforcement and raise the cost of litigation to reap windfalls for themselves, through legislative and regulatory reversion.
Our PQI seeks to gather and provide objective data and research demonstrating how lowering patent quality will inevitably lead to even higher cost and risk for U.S. SMEs, inventors, and manufacturers, and lead to less innovation, fewer U.S. jobs, and a drain on the US economy.
showing the connections between U.S. jobs, manufacturing, and patents.
about abuse by parties—often foreign—asserting low-quality U.S. patents.
from US entrepreneurs and innovators hurt by the current system.
FOR EXAMPLE . . .
Early efforts show that the USPTO’s Patent Trial and Appeal Board’s users are primarily U.S. companies and individuals, and the majority of patent owners are foreign corporations.